Published in

Elsevier, Journal of Thoracic Oncology, 10(15), p. 1647-1656, 2020

DOI: 10.1016/j.jtho.2020.06.011

Links

Tools

Export citation

Search in Google Scholar

A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

Journal article published in 2020 by Solange Peters, Sarah Danson, Baktiar Hasan, Urania Dafni, Niels Reinmuth, Margarita Majem, Kurt G. Tournoy, Michael T. Mark, Miklos Pless, Manuel Cobo, Delvys Rodriguez-Abreu, Lionel Falchero, Teresa Moran, Ana Laura Ortega Granados ORCID, Isabelle Monnet and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO